Skip to content

Lexicon Pharmaceuticals LXRX Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin99.5%0.0pp99.4%0.0pp99.4%+0.2pp99.2%+1.1pp98%0.0pp
Operating margin-34.8%+63.4pp-98.2%-3.8pp-94.4%+108pp-202.6%+366pp-568.6%+65.6pp
Net margin-37.5%+63.6pp-101.1%-4.3pp-96.8%+110pp-206.4%+362pp-568%+76.7pp
Returns
Return on equity-16%+23.7pp-39.7%+6.2pp-45.9%+19.4pp-65.3%+20.8pp-86.1%+81.6pp
Return on invested capital-13.5%+20.1pp-33.5%+4.0pp-37.5%+15.0pp-52.5%+23.8pp-76.3%+32.6pp
Efficiency
Asset turnover0.2×0.0×0.2×-0.1×0.3×+0.1×0.2×+0.1×0.1×0.0×
Liquidity
Current ratio18.8×+13.9×4.9×-0.8×5.6×+1.5×4.2×+1.9×2.2×-3.2×
Leverage
Debt-to-equity0.3×-0.3×0.6×0.0×0.5×+0.1×0.5×-0.4×0.9×+0.1×
Per Share
Book value per share$0.51+71.1%$0.30-10.4%$0.33-7.1%$0.36+4.8%$0.34-25.5%
Valuation
Market capitalization$986.12M+273%$417.91M-14.8%$490.59M+75.4%$279.76M+67.9%$166.58M-37.6%
Price / sales14.2×+5.7×8.4×+1.5×6.9×+2.1×4.8×-0.5×5.3×-3.3×
Price / book+2.8×3.9×-0.2×4.1×+1.9×2.2×+0.8×1.4×-0.5×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Lexicon Pharmaceuticals's profit margins?
Lexicon Pharmaceuticals (LXRX) runs a 99.5% gross margin and a -34.8% operating margin, with a -37.5% net margin.
Where do Lexicon Pharmaceuticals's ratios come from?
Every ratio is computed from Lexicon Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.